Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. - Wikidata - wikimedia - TriplyDB

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

http://www.wikidata.org/entity/Q30586297

about

Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application Targeted therapy for advanced gastric cancer: A review of current status and future prospects Clinical utility of ramucirumab in advanced gastric cancer Multimodal treatment of gastric cancer in the west: Where are we going?Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review Gastric cancer: current and evolving treatment landscape Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC-7901 cells DCF intraperitoneal and intravenous dual chemotherapy regimen for advanced gastric cancer: A feasibility study Cisplatin or not in advanced gastric cancer: a systematic review and meta-analysis.Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment.Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy.Prognostic values of four Notch receptor mRNA expression in gastric cancer.C5b-9 Staining Correlates With Clinical and Tumor Stage in Gastric Adenocarcinoma.Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis.Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?Statistical evaluation of surrogate endpoints with examples from cancer clinical trials.Targeted therapy in gastric cancer.Does surgery have a role in managing incurable gastric cancer?Chemotherapy for advanced gastric cancer.A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses.Crocodile choline from Crocodylus siamensis induces apoptosis of human gastric cancer.RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis.Pathogenesis of Gastric Cancer: Genetics and Molecular Classification.Distinct prognostic values of YAP1 in gastric cancer.Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer.ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.TSPAN8 promotes gastric cancer growth and metastasis via ERK MAPK pathway.Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes The prognostic roles of ALDH1 isoenzymes in gastric cancer.Gastric cancer: toward a cisplatin-free disease?

P2860

Q26744362-84A17785-A3A0-4B07-8BF9-6FEB4882A817 Q26765941-B7C0FA0E-4CBB-42E3-B7B7-79844773ADC4 Q26774138-FE55278E-4BC2-4A11-BC5E-7478FAF57183 Q26785665-18D07028-ACA0-4C10-BF55-602D09F1D548 Q26799748-EA566634-1DC8-495A-8990-FC3B9C25156D Q26801289-72C9521A-D493-47E1-A14D-C6A6114E6CAC Q26860637-37963FA2-5EEE-4FB9-941F-32B8D8D84B01 Q26865748-C4E13E5A-CC7C-408B-A2DA-0F1D2C724615 Q28073757-53D99084-64F2-4923-9A5D-E01398C466B7 Q28468621-94EC0D65-8824-4727-969B-CD83513CD8DB Q33418948-7A010321-6435-4B47-A4BC-9B2A5315DD18 Q35080136-AD6B8883-1161-4820-AF08-BAF3D16864B7 Q36102672-F24C262D-84A0-48E8-AC53-3414EA26BECF Q36234315-DF6247A6-65B1-4403-8578-99F28953C0A8 Q36547753-B4BB75CA-0F94-4C9F-B45A-7A8AFE82C13B Q36631514-536E9387-E122-4C7B-AB30-C929A2E39458 Q37057286-3CC21189-E586-4619-B593-12309BE08A1A Q37164615-59F3951B-9909-493B-A90A-EAF6BA4A8560 Q37197679-B9D68C91-33D3-4BCE-AEC5-0F47E19BEA1B Q37353877-A30B3266-D89A-4A30-B16F-6B258268724F Q37537123-A9D06BCC-AF73-45D0-8F36-8D90AFA47B8C Q37697326-F54DF513-0890-4A01-A5D8-004389ACC3EB Q38184380-AAD94982-5797-4957-BB11-033678284CC4 Q38356102-75DAC281-A75B-4D8F-9502-B4B7819AF7B1 Q38364292-296ACD00-6351-4A50-B34B-AA128A41E1C0 Q38563923-436AC6BD-D929-40AE-BD96-B28B3062CE31 Q38604012-451C0D1B-FD3E-40FE-BE2E-FFEDA4BB834F Q38691539-94DAE43A-4B03-4977-8A97-DA84643BD1A6 Q38710257-E94FB6AB-5C71-4677-AFBF-04D78FFD49F1 Q38749340-29824B1D-2F43-435E-A26C-19D0A20465B6 Q38794776-579A628B-60A0-423E-881B-2EC5104DB7DE Q38941416-9DB75072-757A-4C50-B91B-D5C3641D2763 Q39104058-A2373D9D-0654-4FE4-A1EE-1834401C5811 Q40256327-928D6FC4-5C53-4DF8-A4C4-63CEC1549FD9 Q41271833-FBC0182C-90D7-4DBE-A2E7-624B9B2509CA Q41624746-DAD14B30-1706-4695-902D-2B6A67EEEB36 Q41845256-22CEEE53-86F6-42EF-9AD4-64E09F5B4942 Q41992584-395239A0-7716-4707-BBCF-8E0D32EBAA6D Q42114059-09F8CAAB-2B75-4976-AE54-E97113B6A188 Q42125510-C914B140-D198-4E2E-9B34-6ADEA33AA444

P2860

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

http://www.wikidata.org/entity/Q30586297

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Role of chemotherapy for advan ...... al-patient-data meta-analysis.

@ast

Role of chemotherapy for advan ...... al-patient-data meta-analysis.

@en

type

label

Role of chemotherapy for advan ...... al-patient-data meta-analysis.

@ast

Role of chemotherapy for advan ...... al-patient-data meta-analysis.

@en

prefLabel

Role of chemotherapy for advan ...... al-patient-data meta-analysis.

@ast

Role of chemotherapy for advan ...... al-patient-data meta-analysis.

@en

P1433

Q30586297-3056C4BB-0146-4D32-9028-781A64DC9ABB

P1476

Q30586297-9E3A9B13-A825-44D4-938E-F1A8AB7AA6AE

P2093

Q30586297-0DBD053F-A2B0-4647-84F5-B22C3139838D

Q30586297-494E6A64-E553-4D2B-B0B5-73DD81537214

Q30586297-4A7DD361-B28A-4BEA-83E5-330F18397841

Q30586297-51A0A501-5BA0-4C1E-9C3C-1C594AFD65D3

Q30586297-650B69F8-CB90-465F-A72D-609429D92CFC

Q30586297-6A8BE56D-05AB-4A56-AE80-D94194E0840B

Q30586297-82E5AE27-6FE9-41C8-9575-8F9E796F622F

Q30586297-9883CF4D-87B5-4DC4-8800-5B49933E5496

Q30586297-A5517043-1A67-45A0-B267-37F9D00C7FC2

Q30586297-E8D37F2D-3012-4759-A0E9-FB75A2A10244

P304

Q30586297-6CA06514-ECDD-4330-9AE0-40BB9C130B85

P31

Q30586297-ABE76335-E622-44F6-89ED-DB1262F56779

Q30586297-D3AE40DD-043E-4772-8386-6583F32EDC0F

P356

Q30586297-AE8E89A5-B520-4CE7-A392-78D3391C6B5E

P433

Q30586297-66AC0B04-6FEE-4DA7-B9FB-CAB43409C0EB

P478

Q30586297-B87C21E8-2BC3-4E1F-B798-9A9543056952

P50

Q30586297-1196FC33-148F-4557-BD65-6786C760593F

Q30586297-3D052D78-EAB4-4FAD-8A25-C3190250B153

Q30586297-5B83B2D2-B424-4625-9A56-C41EB62341D5

Q30586297-6B973868-B019-4FE2-889E-9622F17BA2FB

Q30586297-710C599D-AC41-4E3C-8C7E-3D6BA97D464E

Q30586297-8FE67D9D-F05D-46A7-B121-1238C4575B9A

Q30586297-91381ED4-2ED3-4336-A9A6-CD74D4EE92E4

Q30586297-C708C048-D0EF-4B49-8DF3-A8796800CAB2

P577

Q30586297-430201F3-6738-4540-9A5C-473C46C23824

P698

Q30586297-C89CFAA7-1935-4338-979F-EF2406232756

P921

Q30586297-12603050-3E09-422F-ACB8-7DFCF524F941

Q30586297-374DA3F6-F7E5-4825-9452-A6592F61E44B

P356

J.EJCA.2012.12.016

P1433

European Journal of Cancer

P1476

Role of chemotherapy for advan ...... al-patient-data meta-analysis.

@en

P2093

Akira Tsuburaya

http://www.w3.org/2001/XMLSchema#string

GASTRIC (Global Advanced/Adjuv ...... rnational Collaboration) Group

http://www.w3.org/2001/XMLSchema#string

Harry Bleiberg

http://www.w3.org/2001/XMLSchema#string

Junichi Sakamoto

http://www.w3.org/2001/XMLSchema#string

Kohei Shitara

http://www.w3.org/2001/XMLSchema#string

Mitsuru Sasako

http://www.w3.org/2001/XMLSchema#string

Philippe Rougier

http://www.w3.org/2001/XMLSchema#string

Satoshi Morita

http://www.w3.org/2001/XMLSchema#string

Xavier Paoletti

http://www.w3.org/2001/XMLSchema#string

Yasuo Ohashi

http://www.w3.org/2001/XMLSchema#string

P304

1565-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJCA.2012.12.016

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Eric Van Cutsem

Stefan Michiels

Daniel J. Sargent

Jean-Pierre Pignon

Tomasz Burzykowski

P577

2013-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23352439

http://www.w3.org/2001/XMLSchema#string

P921